Abstract
Extremely low frequency electromagnetic radiation (ELF-EMR) is an omnipresent component of electricity, with a frequency of 3-30Hz, and wavelengths 3,450-5,996km long. We reviewed the scientific literature regarding pediatric health effects resulting from chronic exposure to ELF-EMR and compared these with the international safety standards. Articles published between 1980-2007 were identified using Medline, Cancerlite, Science Citation Index, and EMBASE. For the general population, the International Commission on Non-Ionizing Radiation Protection considers chronic exposure to magnetic fields lower than 100μT to be safe. However, even 0.3-0.4μT has been associated with an increased risk of acute lymphoblastic leukemia (ALL) in children. Although there is no experimental model to test the effects of ELF-EMR on organic systems, the Precautionary Principle is fundamental to the protection of children who are exposed to residential radiation doses higher than 0.3μT.
Keywords: Children, environmental risk, policies, electromagnetic fields, power lines
Current Pediatric Reviews
Title: Pediatric Health Effects of Chronic Exposure to Extremely Low Frequency Electromagnetic Fields
Volume: 5 Issue: 4
Author(s): Juan Antonio Ortega-Garcia, Marlene Martin, Enrique Navarro-Camba, Julia Garcia-Castell, Offie P. Soldin and Josep Ferris-Tortajada
Affiliation:
Keywords: Children, environmental risk, policies, electromagnetic fields, power lines
Abstract: Extremely low frequency electromagnetic radiation (ELF-EMR) is an omnipresent component of electricity, with a frequency of 3-30Hz, and wavelengths 3,450-5,996km long. We reviewed the scientific literature regarding pediatric health effects resulting from chronic exposure to ELF-EMR and compared these with the international safety standards. Articles published between 1980-2007 were identified using Medline, Cancerlite, Science Citation Index, and EMBASE. For the general population, the International Commission on Non-Ionizing Radiation Protection considers chronic exposure to magnetic fields lower than 100μT to be safe. However, even 0.3-0.4μT has been associated with an increased risk of acute lymphoblastic leukemia (ALL) in children. Although there is no experimental model to test the effects of ELF-EMR on organic systems, the Precautionary Principle is fundamental to the protection of children who are exposed to residential radiation doses higher than 0.3μT.
Export Options
About this article
Cite this article as:
Antonio Ortega-Garcia Juan, Martin Marlene, Navarro-Camba Enrique, Garcia-Castell Julia, P. Soldin Offie and Ferris-Tortajada Josep, Pediatric Health Effects of Chronic Exposure to Extremely Low Frequency Electromagnetic Fields, Current Pediatric Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339609791317333
DOI https://dx.doi.org/10.2174/157339609791317333 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Central Nervous System Involvement in Pediatric Rheumatic Diseases: Current Concepts in Treatment
Current Pharmaceutical Design Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review
Recent Patents on Anti-Cancer Drug Discovery Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy
Current Gene Therapy Vitamin D and the Adaptive Immune System with Special Emphasis to Allergic Reactions and Allograft Rejection
Inflammation & Allergy - Drug Targets (Discontinued) Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy
Current Pharmaceutical Design Personalizing Medicine from Birth: Are Countries Prepared for the Ethical, Legal, and Social Challenges?
Current Pharmacogenomics and Personalized Medicine Design Potential Selective Inhibitors for Treating Cancer by Targeting the Src Homology 2 (SH2) Domain-Containing Phosphatase 2 (Shp2) with Core Hopping Approach
Protein & Peptide Letters A Review of Studies on Targeting Interleukin 4 Receptor for Central Nervous System Malignancy
Current Molecular Medicine Identification of Genes for a Complex Trait: Examples from Hypertension
Current Pharmaceutical Biotechnology Endocrine Disruptors and Human Health
Mini-Reviews in Medicinal Chemistry Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Ewing’s Sarcoma Cancer Stem Cell Targeted Therapy
Current Stem Cell Research & Therapy Recent Clinical Aspects of Eating Disorders
Reviews on Recent Clinical Trials Patent Selections :
Recent Patents on Biomarkers Current Guidelines for the Use of Fluoride in Pediatric Dentistry, A Review
Applied Clinical Research, Clinical Trials and Regulatory Affairs Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Phage Display Derived Therapeutic Antibodies
Current Pharmaceutical Biotechnology Editorial (Hot Topic: Survival Signaling Through Focal Adhesion Kinase in Tumors)
Anti-Cancer Agents in Medicinal Chemistry Quality of Life in Patients with β-thalassemia Major: Short-term and Long-term Effects After Haematopoietic Stem Cell Transplantation
Current Stem Cell Research & Therapy Epilepsy, Regulation of Brain Energy Metabolism and Neurotransmission
Current Medicinal Chemistry